Des-aspartate-angiotensin I exerts hypoglycemic action via glucose transporter-4 translocation in type 2 diabetic KKAy mice and GK rats

Endocrinology

Volumn 148, Issue 12, 2007, Pages 5925-5932

  Sim, Meng Kwoon ^a   Xu, Xiao Guang ^a   Wong, Yong Chiat ^a   Sim, Sai Zhen ^a   Lee, Kok Onn ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Dept Medicine Endocrinol Diabet   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN I DERIVATIVE; DESASPARTATE ANGIOTENSIN I; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CELL MEMBRANE; CONTROLLED STUDY; CYTOSOL; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; HINDLIMB; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TRANSPORT; RAT; SKELETAL MUSCLE; WESTERN BLOTTING; WISTAR RAT;

ANGIOTENSIN I; ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 4; HYPOGLYCEMIC AGENTS; IMMUNOPRECIPITATION; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; PHOSPHODIESTERASE I; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 36348931660     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0606     Document Type: Article

References (57)

1. Hansson L, Lindholm LH, Niskanen L, Janke J, Hedner T, Niklason A, Luomanmaki K, Danhlof B, de Faire UJ, Morlin C, Karlberg BE, Wester PO, Bjorck JE 1999 Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 353:611-616
2. Yusuf S, Sleight O, Pogue J, Bosch J, Davies R, Dagenais GN 2000 Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcome Prevention Evaluation Study Investigators. N Engl J Med 342:145-153
3. Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristiansson K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman J, Snapinn S 2002 Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359:1004-1010
4. Shiuchi T, Cui TX, Wu L, Nakagami H, Takeda-Matsubara Y, Iwai M, Horiuchi M 2002 ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO. Hypertension 40:329-334
5. Wan CH, Leung N, Lapointe N, Szeto L, Uffelman KD, Giacca A, Rouleau JL, Lewis GF 2003 Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization in increases myocardial glucose uptake in Zucker fatty rats. Circulation 107:1923-1929
6. Shiuchi T, Iwai M, Li HS, Wu L, Min LJ, Li JM, Okumura M, Cui TX, Horiuchi M 2004 Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice. Hypertension 43:1003-1010
7. Velloso LA, Folli F, Sun XJ, White MF, Saad MJ, Kahln CR 1996 Cross-talk between the insulin and angiotensin systems. Proc Natl Acad Sci USA 93:12490-12495
8. Folli F, Kahn RC, Hansen H, Bouchie JL, Feener EP 1997 Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. J Clin Invest 100:2158-2169
9. Nawano M, Anai M, Funaki M, Kobayashi H, Kanda A, Fukushima Y, Inuaki K, Ogihara T, Sakoda H, Onishi Y, Kikuchi M, Yazaki Y, Oka Y, Asano T 1999 Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat. Metabolism 48:1248-1255
10. Wei Y, Sowers JR, Nistala R, Gong H, Uptergove GM, Clark SE, Morris EM, Szary N, Manrique C, Stump CS 2006 Angiotensin II induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells. J Biol Chem 281:35137-35146
11. Iwai M, Li HS, Chen R, Shiuchi T, Wu L, Min LJ, Li JM, Tsuda M, Suzuki J, Tomono Y, Tomochika H, Mogi M, Horiuchi M 2006 Calcium channel blocker, azelnidipine, reduces glucose intolerance in diabetic mice. J Pharmacol ExpTher 319:1081-1087
12. Mehta PK, Griendling KK 2006 Angiotensin II cell signaling: physiological and pathological effects in cardiovascular system. Am J Physiol Cell Physiol 292:C82-C97
13. McFarlane SI, Kumar A, Sowers JR 2003 Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease. Am J Cardiol 91 (Suppl 12A):30H-37H
14. Chua HL, Jois S, Sim MK, Go ML 2004 Transport of angiotensin peptides across the Caco-2 monolayer. Peptides 25:1327-1338
15. Sim MK, Chai SK 1996 Subtypes of losartan-sensitive angiotensin receptor in the rabbit pulmonary artery. Br J Pharmacol 117:1504-1506
16. Min L, Sim MK, Xu XG 2000 Effects of des-aspartate-angiotensin I on angiotensin II-induced incorporation of phenylalanine and thymidine in cultured rat cardiomyocytes and aortic smooth muscle cells. Regul Pept 95:93-97
17. Sim MK, Min L 2005 Des-aspartate-angiotensin I and angiotensin AT1 receptors in rat cardiac ventricles. Regul Pept 129:133-137
18. Sim MK, Min L 1998 Effects of des-Asp-angiotensin I on experimentally-induced cardiac hypertrophy in rats. Int J Cardiol 63:223-227
19. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 22:1462-1470
20. Abdul-Ghani MA, Matsuda M, Balas B, DeFrnzo RA 2007 Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30:89-94
21. Dombrowski L. Roy D, Marcotte B, Marette A 1996 A new procedure for the isolation of plasma membranes, T tubes, and internal membranes from skeletal muscle. Am J Physiol 270:E667-E676
22. Touster O, Aronson NN, Dulaney JT, Hendrickson H 1970 Isolation of rat liver plasma membranes: use of nucleotide pyrophosphatase and phosphodiesterase I as marker enzymes. J Cell Biol 47:604-618
23. Hirose M, Keneki M, Sugita H, Yashuhara S, Martyn JA 2000 Immobilization depresses insulin signaling in skeletal muscle. Am J Physiol Endocrinol Metab 279:E1235-E1241
24. Ueda E, Yoshikawa Y, Ishino Y, Sakurai H, Kojima Y 2002 Potential insulinomimetic agents of zinc(II) complexes with picolinamide derivatives: preparations of complexes, in vitro and in vivo studies. Chem Pharm Bull 50:337-340
25. Miura T, Itoh Y, Iwamoto N, Kato M, Ishida T 2004 Suppressive activity of fruit of Momordica charantia with exercise on blood glucose in type 2 diabetic mice. Biol Pharm Bull 27:248 -250
26. Koyama M, Wada R, Kakuraba H, Mizukami H, Yagihashi S 1998 Accelerated loss of islet β cells in sucrose-fed Goto-Kakizaki rats, a genetic model non-insulin-dependent diabetes mellitus. Am J Pathol 153:537-545
27. Parekh P, Petro AE, Tiler JM, Feinglos MN, Surwit RS 1998 Reversal of diet-induced obesity and diabetes in C57BL/6J mice. Metabolism 47:1089-1096
28. Opara CE, Petro A, Tevrizian A, Feinglos Mn, Surwit RS 1996 L-Glutamine supplementation of high fat diet reduces body weight and attenuates hyperglycemia in C57BL/6J mice. J Nutr 126:273-279
29. Collins S, Martin TL, Surwit RS, Robidoux J 2004 Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav 81:243-248
30. Song XM, Kawano Y, Krook A, Ryder JW, Efendic S, Roth RA, Walberg-Henriksson H, Zierath JR 1999 Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats. Diabetes 48:1-7
31. Braithwaite SS, Palazuk B, Colca JR, Edwards III CW, Hofmann C 1995 Reduced expression of hexokinase II in insulin-resistant diabetes. Diabetes 44:43-48
32. Giani JF, Gironacci MM, Munoz MC, Pena C, Turyn D, Dominici FP 2007 Angiotensin-(1-7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in the rat heart in vivo: role of the AT1 and Mas receptors. Am J Physiol Heart Circ Physiol 293:H1154-H1163
33. Sim MK 1994 Degradation of angiotensin I in the endothelium and smooth muscle of the rat aorta. Biochem Pharmacol 45:1524-1527
34. 1]angiotensin I by a novel aminopeptidase in the rat hypothalamus. Biochem Pharmacol 48:1043-1046
35. Sim MK, Qui XS 2003 Angiotensins in plasma of hypertensive rats and human. Regul Pept 111:179-182
36. Velloso LA, Folli F, Perego L, Saad MJA 2006 The multi-faceted cross-talk between the insulin and angiotensin II signaling systems. Diabetes Metab Res Rev 22:98-107
37. Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smoth RJ, Dohm GL 1995 Insulin receptor phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 95:2195-2204
38. Bandyopadhyay GK, Yu JG, Ofrecio J, Olefsky JM 2005 Increased p85/55/50 expression and decrease phosphatidylinositol 3-kinase activity in insulin-resistant human skeletal muscle. Diabetes 54:2351-2359
39. Linderman JR, Greene AS 2001 Distribution of angiotensin II receptor expression in the microcirculation of striated muscle. Microcirculation 8:275-281
40. Malendowicz SL, Ennezat PV, Testa M, Murray L, Sonnenblick EH, Evans T, LeJemtel TH 2000 Angiotensin II receptor subtype in the skeletal muscle vasculature of patients with severe congestive heart failure. 102:2210-2213
41. Jones A. Woods DR 2003 Skeletal muscle RAS and exercise performance. Int J Biochem Cell Biol 35:855-866
42. Gordon SE, Davis BS, Carlson CJ, Booth FW 2001 Ang II required for optimal overload-induced skeletal muscle hypertrophy. Am J Physiol Endocrinol Metab 280:150-159
43. Chen WS, Sim MK 2004 Effects of des-aspartate-angiotensin I on the expression of angiotensin AT1 and AT2 receptors in ventricles of hypertrophic rat hearts. Regult Pept 117:207-212
44. Wen Q, Sim MK, Tang FR 2004 Reduction of infarct size by orally administered des-aspartate-angiotensin I in the ischemic reperfused rat heart. Regul Pept 120:149-153
45. Sugiura M, Ogawa, Yano M 2006 Effect of chronic administration of fruit extract (Citrus unshiu Marc.) on glucose tolerance in GK rats, a model of type 2 diabetes. Biosci Biotechnol Biochem 70:293-295
46. 2α and indomethacin on the sensitivity of glycolysis and glycogen synthesis to insulin in stripped soleus muscles of the rat. Biochem J 227:337-340
47. Leighton B, Challiss RAJ, Newsholme EA 1990 Role of prostaglandins as modulators of insulin-stimulated glucose metabolism in skeletal muscle. Horm Metab Res Suppl 22:89-95
48. Bishop-Bailey D 2000 Peroxisome proliferator-activated receptors in the cardiovascular system. Br J Pharmacol 129:823-834
49. Paolisso G, KiMaro G, D'Amoe A 1995 Passariello N, Gambardella A, Varricchio M, D'Onofrio F. Low-dose iloprost infusion improves insulin action in aged healthy subject and NIDDM patients. Diabetes Care 18:200-205
50. Wasner HK, Weber S, Partke HJ, Amini-Hadi-Kiashar H 1994 Indomethacin treatment causes loss of insulin action in rats: involvement of prostaglandins in the mechanism of insulin action. Acta Diabetol 31:175-182
51. Dandona P, Aljada A, Bandyopadhyay A 2004 Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25:4-7
52. Bloch-Damti A, Bashan N 2005 Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid Redox Signal 7:1553-1567
53. Akaogi J, Nozaki T, Satoh M, Yamada H 2006 Role of PGE2 and EP receptors in the pathogenesis of rheumatoid arthritis and as a novel therapeutic strategy. Endocr Metab Immune Disord Drug Targets 6:383-394
54. Zhou W, Hahsimoto K, Goleniewska K, O'Neal JF, Ji S, Blackwell TS, FitzGerald GA, Egan KM, Geraci MW, Pebles Jr RS 2007 Prostaglandins I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells. J Imunol 178:702-710
55. + channels via the EP3 receptor. Am J Physiol Heart Circ Physiol 288:H2093-H2101
56. Miura T, Kubo M, Itoh Y, Iwamoto N, Kato M, Park SR, Ukawa Y, Kita Y, Suzuki I 2002 Antidiabetic activity of Lyophyllum decastes in genetically type 2 diabetic mice. Biol Pharm Bull 25:1234-1237
57. Lo HC, Tu ST, Lin KC, Lin SC 2004 The anti-hyperglycemic activity of the fruiting body of Cordyceps in diabetic rats induced by nicotinamide and streptozotocin. Life Sci 74:2897-2908.